Prediabetes in children and adolescents: An updated review

Abstract

Prediabetes, the precursor of type 2 diabetes mellitus, is an intermediate stage between normal glucose homeostasis and overt diabetes. This asymptomatic metabolic state is increasingly prevalent in pediatric population and is very difficult to detect without appropriate screening. Studies have shown that a certain proportion of children with prediabetes will develop diabetes in a few years. Even more alarming is the evidence that youth-onset diabetes has a more aggressive clinical course with progressive beta-cell decline and accelerated end-organ damage. Despite its importance, several aspects involving prediabetes in childhood are disputed or unknown. This review presents the latest insights into this challenging entity and outlines a simplified screening approach to aid clinical practice. In summary, childhood prediabetes is an important clinical condition indicating the need for proper screening and timely intervention.

Key Words: Prediabetes; Screening; Diagnosis; Management; Obesity; Type 2 diabetes mellitus; Children

Core Tip: Prediabetes, an intermediate stage before type 2 diabetes mellitus, has increased in parallel with the growing burden of pediatric obesity worldwide. However, child health practitioners are struggling with the definition, significance, diagnostic approach, trajectories, implications, outcomes, and management of prediabetes. This review aims to provide pediatricians and primary care providers with an updated overview of this important, yet controversial, condition.

INTRODUCTION

Childhood obesity has long been a public health challenge worldwide and has emerged as one of the most significant concerns. It poses an enormous health burden. The prevalence of childhood obesity has increased exponentially in recent years. This is further exacerbated by the novel coronavirus disease 2019 (COVID-19) pandemic, which negatively impacted the lifestyle and nutritional habits of children[1-3].

Prediabetes is a prominent clinical condition characterized by asymptomatic prodromal phase before the onset of diabetes mellitus. In adult population, prediabetes is considered a precursor to type 2 diabetes mellitus (T2DM)[4]. It is therefore tempting to infer a dramatic rise in prediabetes among pediatric population, given the increase in the prevalence of both obesity and T2DM in childhood[5]. A recent systematic review and meta-analysis showed a rapid increase in the prevalence of prediabetes in children globally. The pooled prevalence of 48 community-based studies was up to 8.84%[6]. Notably, prediabetes in children is associated with youth-onset T2DM, which is regarded as a more aggressive entity with increased cardiovascular and metabolic risk[7,8]. Significant damage to beta-cells may also occur prior to the development of dysglycemia[9]. The various adverse health effects in adulthood can be traced to prediabetes in childhood[10]. Fortunately, the occurrence and progression of dysglycemia in T2DM is more insidious compared with type 1 diabetes mellitus (T1DM) allowing more time for prevention and intervention.

Early diagnosis and management via screening represents a unique opportunity to intervene and is both logical and appealing. However, our current understanding of childhood prediabetes is mainly based on studies involving adult population and is poorly characterized[10]. The diagnosis and management of this important clinical condition is still imperfect, and is often disputed and debated. Thus, the need for a literature review to identify the latest evidence, insight and knowledge gaps cannot be overstated.

With this background, a comprehensive literature search was conducted in an effort to provide an overview of current understanding regarding prediabetes. It covers the latest epidemiology, diagnostic means, related controversies, and the need for future research. The span of our review is limited to articles published within the last 10 years in an effort to provide pediatricians and primary care providers with recent updates of this complex yet important condition.

LITERATURE SEARCH

For this narrative review, a literature search was conducted using MEDLINE, EMBASE, RCA, and Google Scholar databases. Search terms included “prediabetes”, “hyperglycemia”, “dysglycemia”, “abnormal glucose homeostasis”, “children”, and “adolescents”. Articles published between January 2013 to March 2023 were considered with the exception of landmark studies or articles. Additional publications were also retrieved by snowballing.

Specifically, articles reporting prediabetic children younger than 18 years old were reviewed, with full-text available in English. Exclusion criteria included T1DM (autoimmune β-cell destruction), gestational diabetes mellitus (GDM), and other specific types of diabetes, such as monogenic diabetes syndromes, pancreatogenic diabetes, and drug-induced diabetes[11].

CHILDHOOD OBESITY

Childhood obesity has evolved into a major public health crisis both in developed and developing countries[12-14]. Globally, studies showed a high level of obesity and a rising trend particularly in low-and middle-income countries[15]. The United Nations Children’s Fund estimated that 380 million children below 19 years of age were overweight, with the rate increasing to 18% in 2018 from 10% in 2000 among 5- to 19-year-old individuals[16].

The situation is further complicated by the unprecedented public health challenge due to coronavirus disease 2019 (COVID-19) pandemic. Response to global COVID-19 pandemic by decision-makers had a further impact on the obesity landscape as more than 80% of children worldwide experienced school closures, movement restrictions, physical inactivity, and drastic changes to their way of life[13,17,18]. These changes in lifestyle, daily routines, and nutritional habits contributed to weight gain[3]. Consequently, a significant rise in childhood obesity is imminent and inevitable[19,20].

Recently, two systemic reviews and meta-analyses demonstrated a significant increase in weight gain, body mass index (BMI), and prevalence of obesity in children during the COVID-19 pandemic[21,22]. In another study evaluating the net impact of the COVID-19 Lockdown, Dietz[23] reported that the changes in obesity prevalence among children aged below 12 years were 28- to 37-fold higher than the annual expected changes observed in the National Health and Nutrition Examination Survey of United States. Particularly, the highest weight gain observed among youth with severe obesity was a cause for serious concern[24]. As the obesity rates and levels continue to rise in childhood, the prevalence of prediabetes and diabetes in children also increases rapidly with alarming trends worldwide[6].

TYPE 2 DIABETES MELLITUS

In brief, the pathophysiology of T2DM involves insulin resistance (IR) accompanied by insufficient insulin release[8,9,25]. Clinical signs suggesting insulin resistance, such as acanthosis nigricans, are risk factors indicated in various guidelines. Acanthosis nigricans is closely associated with insulin resistance and provides a prominent visual cue that can aid in early intervention[25-28]. Although the underlying risk for IR is not completely understood, genetic and environmental factors are largely implicated[8,25].

Youth-onset T2DM is a more aggressive disease with rapid deterioration of beta-cell function and poor response to treatment. Eventually, it progresses to complications more rapidly and earlier than in adult-onset T2DM, impacting the most productive years of life[29-33]. A substantial number of patients with youth-onset T2DM exhibit micro-vascular and macro-vascular complications in the early stages of the disease, suggesting prior ongoing vascular damage[34]. In an observational study of 500 cases of youth-onset T2DM conducted over 10 years, the cumulative incidence of hypertension, dyslipidemia, retinal disease, and diabetic kidney disease recorded exceeded 50%. Among these participants who were diagnosed with diabetes for 13.3 years (mean), 28.4% carried more than two diabetes complications at a mean age of 26.4 years[35]. At the time of first diagnosis, youth-onset T2DM often presents with comorbidities, including but not limited to hypertension, dyslipidemia, and hepatosteatosis[36]. Given this grim threat, early identification of youth who are at-risk is imperative.

PREDIABETES

Prediabetes is a condition that is characterized by dysregulated glucose homeostasis[25]. Advocating prediabetes as a distinct pathological condition is controversial despite its recent inclusion in the ICD-10 coding[37,38]. While some authors caution against medicalization of prediabetes[39,40], others believe that it is essential and helpful to encourage positive lifestyle changes[41,42]. Emerging evidence suggests that individuals with prediabetes have pathophysiological changes in organs that are traditionally affected by diabetes, further validating it as a distinct disease entity[37].

Prevalence

For decades, the global prevalence of prediabetes in children was largely unknown. A recent systematic review and meta-analysis of 6630296 participants from 48 community-based pediatric studies found that the pooled prevalence of childhood prediabetes was 8.84% [95%CI (6.74, 10.95)] using a random-effects model. However, these data should be interpreted with caution given the heterogeneity of included studies, potential publication bias, and limited comparability based on different definitions and study designs[6]. Generally, the prevalence of prediabetes is substantially higher in the cohort targeting children with obesity. In an Italian study, the prevalence was 21.1%[43]. Our group demonstrated a prevalence of 15.4% in 879 Chinese pediatric patients from Hong Kong[44]. Another study conducted in German-speaking countries reported a prevalence of 11.9%[45]. Prevalence rate increases with age or deteriorating weight status[43,44].

Natural history

Despite the large number of studies involving T2DM in children, little is known about the natural history of prediabetes, which is an intermediate stage along the continuum of normal glucose regulation to overt diabetes[10,46-48]. Using data from a cohort of White Canadian children with a parental history of obesity, Harnois-Leblanc et al[49] reported that 73% of children with prediabetes at baseline (8-10 years of age) reverted to normoglycemia by the end of adolescence. In contrast, only 53% of children with prediabetes detected at 10-12 years of age reverted to normoglycemia at 15-17 years of age. However, it should be noted that their complete cohort (with complete 7-year data covering the three evaluations) consisted of 350 children, including those with normal weight. Hence, the prevalence of dysglycemia was only 10% at baseline and first evaluation. Indeed, what is more alarming is that one in five children (21%) in their cohort, recruited based on parental history of obesity, developed prediabetes or diabetes over 7 years.

In another multiethnic, prospective observational study carried out in the United States, 526 adolescents with obesity completed two evaluations with a median follow-up of 2.9 years. Galderisi, Giannini[50] reported that 65% adolescents with dysglycemia at baseline (n = 162) reverted to normal glycemia. Notably, the remaining 27% showed persistent dysglycemia and 8% progressed to T2DM. One of the strengths of their study was confirmation of T2DM with a second oral glucose tolerance test to eliminate any reproducibility issue. Although it was an observational study, the standard of care during follow-up included dietary assessment and advice every 6 mo, suggestion to limit sugary drinks and screen time, and promotion of physically active lifestyle.

A recent search of PubMed/ MEDLINE and the Cochrane Library for articles published through May 3, 2021 by the United States Preventive Services Task Force (USPSTF) revealed few studies suggesting that 22% to 52% children and adolescents with prediabetes returned to normal glycemia without intervention over 6 mo to 2 years[51].

Understanding the natural history of disease is critical to recognizing and responding to preventive efforts. It offers a framework to conceptualize the illness and preventive strategies. In a strict sense, the natural history of a disease refers to the natural progression over time without any treatment or intervention. In modern medicine, this is constructed from multiple sources to form a composite clinical picture of underlying disease dynamics[41].

Outlining the real natural progression of prediabetes in children is of great interest to clinicians. However, children with prediabetes are mostly asymptomatic and cannot usually be identified. If they are screened due to obesity, health care providers are obligated to provide appropriate advice regarding dietary and lifestyle intervention. Even in a research setting, children and family are not blinded to their blood test results because it is not ethical to do so. Under such circumstances, they may exert substantial efforts to prevent further progression[34]. Simply informing participants of their abnormal results, even without intervention, can improve their dysglycemia[52]. This argument is supported by a retrospective cohort study in United States. Using data from the Children’s Hospital of Philadelphia Primary Care Network, Vajravelu et al[53] found a stable BMI Z-score trajectory in all adolescents screened for prediabetes comparing with unscreened individuals. The improvement was even more striking among youth testing positive for prediabetes, suggesting that screening may have an important role in motivating the youth to take appropriate measures to diminish the risk. Indeed, screening and education about prediabetes can improve follow-up rates[54]. Therefore, caution is necessary when interpretating and extrapolating clinical research findings. Also, participants included in the analysis of the “natural course” of disease are those attended follow-up, and with complete data available. It is well known that a large number of children and adolescents are lost to follow-up, even after they are diagnosed with T2DM[36,55,56]. It is inaccurate or misleading to assume that more than half of these dysglycemic children will revert to normal glycemia eventually.

Screening of prediabetes, strategies and limitations

Early detection and timely intervention of dysglycemia can delay or prevent microvascular complications in adults[48]. While screening for prediabetes and T2DM in adults is considered cost-effective, it is highly complicated in children[57-60]. The latest USPSTF concluded that evidence to recommend screening for prediabetes in asymptomatic children and adolescents is unavailable[61]. Explicitly, their position is neither for nor against screening prediabetes. Pediatricians and health care providers should continue to use their clinical judgement in deciding whether or not screening is warranted[61,62].

Going back to year 2000, a consensus group of expert representatives from American Academy of Pediatrics (AAP) and the American Diabetes Association (ADA) first recommended screening of asymptomatic youth carrying at least two risk factors[63,64]. In view of persistent surge in prevalence and incidence of prediabetes, the ADA expanded its recommendation to include youth with only one risk factor in 2018[65]. In the latest publication, ADA continuously recommends screening of high-risk children and adolescents. Screening should be carefully considered in children and youth with overweight or obesity who have at least one of the following risk factors: maternal diabetes or GDM; family history of T2DM; vulnerable race or ethnicity; and signs or conditions associated with insulin resistance. Screening should be started when they turn 10 years of age, or after the onset of puberty, whichever occurs first. Testing should be repeated in cases of deteriorating BMI or risk factor profiles, or at a minimum of 3-year intervals[11]. Currently, the International Society for Pediatric and Adolescent Diabetes (ISPAD) recommends risk-based screening, which is largely similar to the one recommended by ADA[48,66]. By adopting such strategy, it is hoped that early diagnosis can enable early interventions to slow down or prevent disease progression[57,67,68]. In a recent study, the prevalence of dysglycaemia was found to be 23% with individuals carrying only one risk factor referred for assessment in an academic center, suggesting that a single risk factor is sufficient to warrant screening[69].

Despite most authorities proposing risk-based screening, the optimal or the best strategy remains a matter of debate[43,62]. According to the latest ADA and ISPAD recommendations, fasting plasma glucose (FPG), 2-h plasma glucose level measured during oral glucose tolerance test (OGTT), and hemoglobin A1c (HbA1c) can be used to diagnose prediabetes and diabetes in childhood and adolescence[48,70]. Notably, studies reveal an overlap among the subgroups using different diagnostic tests and criteria. The three different tests cannot identify consistently the same group of individuals[43,71]. Indeed, it is now believed that each individual test may analyze different components of glucose metabolism[7,72]. This may complicate the understanding and comparison of this condition in different clinical studies[73]. The prevalence of prediabetes will differ largely if disparate test combinations are used[6,62], and the discussion is further complicated by the different impaired fasting glucose cutoffs adopted by international organizations[73-76]. Additionally, the cutoff thresholds used are derived and adopted from adult studies instead of longitudinal prospective studies involving children and adolescents. The suitability of these criteria will remain a matter of debate for years to come[48,62].

In accordance with ADA, prediabetes should be viewed as risk factor for developing diabetes and cardiovascular disease. The risk starts below the lower end of the reference range and increases largely toward the higher end of the range, and is continuous[75]. Despite its reversibility in some children, prediabetes suggests that the beta-cell function is at its maximal capacity, predisposing to future failure[77].

HbA1c: According to ADA, an HbA1c value of 5.7%-6.4% has been used to define prediabetes in children[75]. It is an indicator of the average blood glucose concentration over the past three months. This test should be performed using a method that is certified by the National Glycohemoglobin Standardization Program to minimize bias[78]. It has the advantages of being stable at room temperature, without the need for fasting, and is associated with minimal day-to-day variations. Nonetheless, ethnic, racial, and age differences in levels of HbA1c exist. Medical conditions, such as anemia, hemoglobinopathies, malaria, and post transfusion, which affect red cell turnovers can affect its validity. Various medications and supplements may also interfere with the assay and alter the value[72,79,80]. It is also noteworthy that the use of HbA1c in children remains controversial[79,81]. The recommendation in adult population is based on epidemiological studies[75]. Some pediatric studies using adult cutoff underestimated the prevalence of diabetes and prediabetes[79,82]. In a study involving Caribbean and African-American children with obesity, investigators found that HbA1c alone, using adult cutoff value, is not a good differentiator of dysglycemia[83]. In recent studies from different countries and jurisdictions, various HbA1c values had been suggested[81,82,84]. This is not surprising as HbA1c is known to depend on age, race, and ethnicity. Further, in a large cohort of ethnically and racially diverse youth (n = 4603) who have normal weight and are otherwise healthy, researchers found that 2.2% have HbA1c values exceeding ADA cutoff, which prompted clinicians to apply and adopt the cutoff value cautiously[48,85]. In sum, the optimal operational HbA1c cutoff in children remains uncertain and requires further study.

FPG and OGTT: FPG has been included as a screening test for dysglycemia in a majority of guidelines regarding management of youth with obesity[86]. It requires a single blood test and is easily available in all laboratories. However, it requires fasting and the result is affected by illness, stress, and time of the day[62,87]. Besides, it is not capable of detecting impaired glucose tolerance (IGT), which is common in children with prediabetes.

OGTT has been considered the “gold standard” for many decades although it has disadvantages of fasting requirement, complicated testing logistics, and reproducibility issues[72,85,88,89]. Although not ideal, it is the only test to assess post-prandial hyperglycemia[77]. Clinically, some individuals may have hyperglycemia only if challenged with a glucose load[48]. If OGTT is not done, half of children with prediabetes were missed in a Korean study[81]. We also demonstrated that 73% of children with prediabetes or diabetes were left out in a large cohort of Chinese Hong Kong Children. IGT is related to insulin resistance in the muscle and defective insulin secretion[90]. This phenotype was found to be associated with a worse cardiometabolic profile[91-93] and a high risk of developing T2DM and cardiovascular disease[57,62,93]. Contrary to usual belief, OGTT was well tolerated in our cohort of children and adolescents with more than 99.8% success rate[44]. Accordingly, it is suggested as the preferred screening method by some experts[94].

Additional parameters, or morphological features, can be obtained during OGTT at the expense of multiple venipunctures. These include but not limited to 1-hour glucose concentration, glucose response curve, and time to glucose peak. They are being investigated as a tool for prediabetes risk stratification. Nevertheless, further research and longitudinal studies are needed before their clinical utility can be considered[62,94-96].

Alternative tests or approaches: Instead of using OGTT, various studies have attempted to use a combination of blood tests or parameters, in an attempt to detect prediabetes. Combining fasting glucose with homeostatic model assessment of insulin resistance (HOMA-IR) cutoff of 3.4, van der Aa, Fazeli Farsani[97] detected all cases of diabetes while missing 36% of IGT. Poon et al[98] derived a clinical pathway using family history, HbA1c, and alanine transaminase. They omitted 50% of OGTTs, but 18.3% of children with dysglycemia were overlooked. Alternative glycemic markers, such as 1,5-anhydroglucitol, glycated albumin, and fructosamine, have been studied as screening tools. However, relevant and meaningful cutoff values associated with long-term risk and complications are still under investigation in pediatric population[62,99]. With the advent of diabetes technology, continuous glucose monitoring (CGM) is more capable of capturing detailed information and parameters of glucose fluctuations. There has been a growing interest in applying CGM technology in non-diabetic individuals[100]. However, its use in predicting prediabetes is still exploratory and preliminary[101].

Screening algorithms

Even though some management algorithms are reported in the literature, there is no consensus on the optimal screening approach for prediabetes and diabetes in children with obesity[10]. Magge et al[80] proposed a management algorithm for screening of high-risk youth. However, it is based on the definition of high risk as two or more risk factors instead of the 2018 ADA recommendation of a single risk factor or more. Nonetheless, it is complicated for daily clinical use. In a recent review article, Garonzi et al[62] proposed a flowchart based on the strengths and weaknesses of different screening tests, suggesting screening of children and adolescents with overweight or obesity using FPG and HbA1c. In case of abnormal findings, OGTT was suggested. Likewise, OGTT was recommended for high-risk children (with one or more risk factors).

To further simplify and streamline the screening process, we suggest a fasting glucose-based approach for overweight and obese children. An OGTT-based approach is warranted in the presence of risk factors suggested by the ADA. HbA1c is considered optional in both approaches as there is no evidence-based operational cutoff value. Limited data support the use of HbA1c in children and adolescents. Figure 1 outlines the simplified framework, as a starting point, for laboratory assessment.

Figure 1 Simplified approach for risk-based dysglycemia screening in asymptomatic children and adolescents. ¹Risk factors adopted from American Diabetes Association[75]. OGTT: Oral glucose tolerance test; FPG: Fasting plasma glucose; HbA1c: Hemoglobin A1c.

MANAGEMENT OF PREDIABETES

Presumably, early identification of children at risk enables practitioners to intervene and interrupt the progression toward diabetes[102]. In the absence of consensus regarding optimal management of children with prediabetes, lifestyle interventions are still the cornerstone in this population[7,28]. A balanced diet consisting of adequate fruits and vegetables, less sugar and processed foods is key. Home-cooked meals are preferred to dining out. Regular daily exercise with limitation of screen time should be reinforced. Innovative strategies for patient education should be explored so that knowledge can be translated into behavioral changes[8,103,104].

Currently, there is no United States Food and Drug Administration (FDA)-approved pharmacologic agent for prediabetes in children. Nevertheless, metformin has been used off-label in pediatric weight-management programs for children with prediabetes and insulin resistance. It is relatively well tolerated with gastrointestinal intolerability being the most common side effect[34,55]. Lactic acidosis is rare and can be monitored during treatment[34,105]. Proponents suggest metformin as a second-line management in those refractory to lifestyle interventions[34]. Liraglutide, a glucagon-like peptide-1 receptor agonist, was approved by the FDA in 2019 for use in childhood T2DM[106]. It may improve beta-cell mass and function and represents a potential treatment for prediabetes in future[56,107].

FUTURE PERSPECTIVES

The recent USPSTF attempted to search for direct evidence supporting screening of asymptomatic children for prediabetes and T2DM to improve health outcomes. However, their commissioned review found insufficient evidence to assess any benefits or harms of screening, mainly, due to a lack of studies[51,60,61]. The lack of prospective long-term longitudinal data to inform evidence-based practice for disease prevention and complication avoidance is the real challenge and major gap in pediatric prediabetes research. Clinical trials of pharmaceutical agents face the challenge of inadequate number of participants[108]. Further, the use of different screening tests and cutoff values in studies has led to discrepant results in different race and ethnicity. A “one-size-fits-all” approach may not be the best, suggesting the need for further validation[72]. Additionally, randomized controlled trials are urgently needed to evaluate the effectiveness of various preventive and management options in prediabetes[109].

CONCLUSION

Prediabetes is increasingly common in childhood and frequently goes unnoticed. It remains a challenging entity facing child health practitioners. Traditionally, it is diagnosed using adult criteria, which may not be readily applicable for children. This extrapolation of adult data is problematic and results in controversial and questionable approaches to prognosis, diagnostic criteria, investigation strategies, and management. The latest AAP guideline alerts pediatricians and healthcare providers to be aware of the pros and cons of each test based on clinical context, patient preferences, and accessibility issues[110]. Apparently, until effective prevention measures for childhood obesity can be found, managing and reversing the growing crisis of diabetes and prediabetes is still a major challenge.